Akari Therapeutics PLC (AKTX) — Cash Flow-to-Debt Ratio
Akari Therapeutics PLC (AKTX) has a Cash Flow-to-Debt Ratio of -0.16x as of December 2025, meaning its operating cash flow of $-3.04 Million could theoretically repay 0% of its total liabilities ($19.56 Million) in one year. See Akari Therapeutics PLC free cash flow ratio to measure how efficiently the company converts operating cash flow to free cash.
CF-to-Debt Ratio
Operating Cash Flow
Total Liabilities
Data as of
Akari Therapeutics PLC Cash Flow-to-Debt Ratio (2010–2025)
Historical debt coverage capacity for Akari Therapeutics PLC across 16 annual periods. Also explore net asset growth rate of Akari Therapeutics PLC to track the company's year-over-year net asset growth rate.
Annual Cash Flow-to-Debt Ratio for Akari Therapeutics PLC (2010–2025)
Year-by-year debt coverage analysis for Akari Therapeutics PLC. For market capitalisation and broader financial context, see AKTX stock market capitalisation.
| Year | CF-to-Debt Ratio | Operating CF (USD) | Total Liabilities | YoY Change |
|---|---|---|---|---|
| 2025 | -0.54x | $-10.57 Million | $19.56 Million | ▼ -21.9% |
| 2024 | -0.44x | $-12.55 Million | $28.33 Million | ▲ +87.6% |
| 2023 | -3.58x | $-16.43 Million | $4.58 Million | ▼ -100.7% |
| 2022 | -1.79x | $-21.50 Million | $12.04 Million | ▲ +42.3% |
| 2021 | -3.09x | $-18.85 Million | $6.09 Million | ▲ +4.7% |
| 2020 | -3.25x | $-16.95 Million | $5.22 Million | ▼ -62.6% |
| 2019 | -2.00x | $-12.92 Million | $6.47 Million | ▲ +72.8% |
| 2018 | -7.33x | $-22.54 Million | $3.08 Million | ▼ -110.3% |
| 2017 | -3.48x | $-31.60 Million | $9.07 Million | ▼ -66.5% |
| 2016 | -2.09x | $-24.62 Million | $11.77 Million | ▼ -792.0% |
| 2015 | -0.23x | $-4.97 Million | $21.17 Million | ▲ +96.0% |
| 2014 | -5.81x | $-9.46 Million | $1.63 Million | ▼ -115.3% |
| 2013 | -2.70x | $-5.45 Million | $2.02 Million | ▼ -467.0% |
| 2012 | -0.48x | $-2.13 Million | $4.48 Million | ▼ -18.7% |
| 2011 | -0.40x | $-1.01 Million | $2.51 Million | ▼ -126.2% |
| 2010 | -0.18x | $-366.00K | $2.06 Million | — |